As of 2024-12-14, the Relative Valuation of Alliance Pharma PLC (APH.L) is (85.61) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 48.75 GBP, the upside of Alliance Pharma PLC based on Relative Valuation is -275.6%.
The range of the Relative Valuation is (73.29) - (103.47) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 16.8x | 12.8x |
| Forward P/E multiples | 11.9x - 18.8x | 15.0x |
| Fair Price | (73.29) - (103.47) | (85.61) |
| Upside | -250.3% - -312.2% | -275.6% |
| Date | P/E |
| 2024-11-25 | -7.39 |
| 2024-11-22 | -7.39 |
| 2024-11-21 | -7.23 |
| 2024-11-20 | -7.19 |
| 2024-11-19 | -7.31 |
| 2024-11-18 | -7.47 |
| 2024-11-15 | -7.65 |
| 2024-11-14 | -7.58 |
| 2024-11-13 | -7.48 |
| 2024-11-12 | -7.57 |
| 2024-11-11 | -7.70 |
| 2024-11-08 | -7.62 |
| 2024-11-07 | -7.63 |
| 2024-11-06 | -7.74 |
| 2024-11-05 | -7.51 |
| 2024-11-04 | -7.31 |
| 2024-11-01 | -7.36 |
| 2024-10-31 | -7.27 |
| 2024-10-30 | -7.55 |
| 2024-10-29 | -6.97 |
| 2024-10-28 | -7.00 |
| 2024-10-25 | -7.34 |
| 2024-10-24 | -7.31 |
| 2024-10-23 | -7.37 |
| 2024-10-22 | -7.32 |
| 2024-10-21 | -7.25 |
| 2024-10-18 | -7.40 |
| 2024-10-17 | -7.42 |
| 2024-10-16 | -7.41 |
| 2024-10-15 | -7.49 |
| 2024-10-14 | -7.31 |
| 2024-10-11 | -7.31 |
| 2024-10-10 | -7.31 |
| 2024-10-09 | -7.08 |
| 2024-10-08 | -6.79 |
| 2024-10-07 | -6.88 |
| 2024-10-04 | -6.91 |
| 2024-10-03 | -7.06 |
| 2024-10-02 | -7.23 |
| 2024-10-01 | -7.27 |
| 2024-09-30 | -7.09 |
| 2024-09-27 | -6.74 |
| 2024-09-26 | -6.82 |
| 2024-09-25 | -6.84 |
| 2024-09-24 | -6.95 |
| 2024-09-23 | -6.95 |
| 2024-09-20 | -6.97 |
| 2024-09-19 | -6.97 |
| 2024-09-18 | -6.72 |
| 2024-09-17 | -6.80 |